Inhibrx Biosciences Inc (INBX) Stock Price, Quote, News & History

INBXNASDAQ
$99.61
-0.79-0.79%
At close: Sep 25, 5:00 PM EST
$99.61
N/A
After Hours: Sep 25, 4:01 PM EST

Inhibrx Biosciences (INBX) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-131.89M
Investing Cash Flow (TTM)
-7.00K
Financing Cash Flow (TTM)
78.67M
Free Cash Flow (TTM)
-131.90M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-53.22M

Analyst Trends and Forecast

1
Apr
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.51B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-8.84%
Earnings Yield % (FWD)
-8.43%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$3.60

Company Debt

Total Debt
$176.29M
LT Debt
$176.29M
LT Debt Issuance (TTM)
$74.99M
LT Debt Repayment (TTM)
-
Total Cash
$133.34M
Debt to Equity
-
Issuance of Debt (TTM)
$74.99M
Repayment of Debt (TTM)
-

Key Statistics

Open
$101.29
Close
$99.61
Volume / Avg.
158.66K / 316.07K
Day Range
$98.09 - $101.29
52 Wk Range
28.16 - 155.29
Market Cap
$1.47B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
41
Short Interest
30.78%
Days to Cover
8.31

About

Sector
Health Care
Industry
Biotechnology
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates inc...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Inhibrx Biosciences (INBX) stock?

A

You can purchase shares of Inhibrx Biosciences (NASDAQ:INBX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Inhibrx Biosciences (INBX) competitors?

Q

What is the forecast, or price target, for Inhibrx Biosciences (INBX) stock?

A

Inhibrx Biosciences has a consensus price target of $197.50.

Q

What is the current price for Inhibrx Biosciences (INBX)?

A

The stock price for Inhibrx Biosciences (NASDAQ: INBX) is $99.61 last updated September 25, 2026 at 4:01 PM EDT.

Q

Does Inhibrx Biosciences (INBX) pay a dividend?

A

There are no upcoming dividends for Inhibrx Biosciences.

Q

When is Inhibrx Biosciences (NASDAQ:INBX) reporting earnings?

A

Inhibrx Biosciences does not have any upcoming earnings scheduled.

Q

Is Inhibrx Biosciences (INBX) going to split?

A

There is no upcoming split for Inhibrx Biosciences.

Q

What sector and industry does Inhibrx Biosciences (INBX) operate in?

A

Inhibrx Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.